Cargando…

Refining Long-Term Prediction of Cardiovascular Risk in Diabetes – The VILDIA Score

Cardiovascular risk assessment in patients with diabetes relies on traditional risk factors. However, numerous novel biomarkers have been found to be independent predictors of cardiovascular disease, which might significantly improve risk prediction in diabetic patients. We aimed to improve predicti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goliasch, Georg, Silbernagel, Günther, Kleber, Marcus E., Grammer, Tanja B., Pilz, Stefan, Tomaschitz, Andreas, Bartko, Philipp E., Maurer, Gerald, Koenig, Wolfgang, Niessner, Alexander, März, Winfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498499/ https://www.ncbi.nlm.nih.gov/pubmed/28680124 http://dx.doi.org/10.1038/s41598-017-04935-8

Ejemplares similares

Additional Use of Glycated Hemoglobin for Diagnosis of Type 2 Diabetes in People Undergoing Coronary Angiography Reveals a Subgroup at Increased Cardiovascular Risk
por: Silbernagel, Guenther, et al.
Publicado: (2011)

A Variant In the Abo Gene Explains the Variation in Soluble E-Selectin Levels—Results from Dense Genotyping in Two Independent Populations
por: Karakas, Mahir, et al.
Publicado: (2012)

Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study)
por: Kleber, Marcus E, et al.
Publicado: (2010)

C-Peptide Levels Are Associated With Mortality and Cardiovascular Mortality in Patients Undergoing Angiography: The LURIC study
por: Marx, Nikolaus, et al.
Publicado: (2013)

Immune Activation and Inflammation in Patients with Cardiovascular Disease Are Associated with Higher Phenylalanine to Tyrosine Ratios: The Ludwigshafen Risk and Cardiovascular Health Study
por: Murr, Christian, et al.
Publicado: (2014)

Glycated Hemoglobin Predicts All-Cause, Cardiovascular, and Cancer Mortality in People Without a History of Diabetes Undergoing Coronary Angiography
por: Silbernagel, Guenther, et al.
Publicado: (2011)

Immunomodulatory treatment for lymphocytic myocarditis—a systematic review and meta-analysis
por: Winter, Max-Paul, et al.
Publicado: (2018)

Anemia of Chronic Disease in Patients With Cardiovascular Disease
por: Lanser, Lukas, et al.
Publicado: (2021)

Labordiagnostik von Fettstoffwechselstörungen
por: März, Winfried, et al.
Publicado: (2023)

Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
por: Thomas, G. Neil, et al.
Publicado: (2012)

Independent Effects of Kidney Function and Cholesterol Efflux on Cardiovascular Mortality
por: Ritsch, Andreas, et al.
Publicado: (2022)

Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women
por: Wehr, Elisabeth, et al.
Publicado: (2011)

The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020)

Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study—Impact for mortality
por: Woitas, Rainer P., et al.
Publicado: (2017)

Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
por: Ritsch, Andreas, et al.
Publicado: (2020)

Neprilysin as a Biomarker: Challenges and Opportunities
por: Pavo, Noemi, et al.
Publicado: (2020)

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
por: Wallentin, Lars, et al.
Publicado: (2021)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
por: Silbernagel, Günther, et al.
Publicado: (2022)

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2011)

Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography—The LURIC study
por: Scharnagl, Hubert, et al.
Publicado: (2014)

Cardiovascular risk algorithms in primary care: Results from the DETECT study
por: Grammer, Tanja B., et al.
Publicado: (2019)

Author Correction: Cardiovascular risk algorithms in primary care: Results from the DETECT study
por: Grammer, Tanja B., et al.
Publicado: (2020)

Circulating Dopamine and C-Peptide Levels in Fasting Nondiabetic Hypertensive Patients: The Graz Endocrine Causes of Hypertension study
por: Tomaschitz, Andreas, et al.
Publicado: (2012)

Impact of Right Ventricular Performance in Patients Undergoing Extracorporeal Membrane Oxygenation Following Cardiac Surgery
por: Bartko, Philipp E., et al.
Publicado: (2017)

Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
por: Prausmüller, Suriya, et al.
Publicado: (2021)

PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
por: Rogacev, Kyrill S., et al.
Publicado: (2016)

Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial
por: Ernst, Jana B., et al.
Publicado: (2016)

Are soluble ST2 levels influenced by vitamin D and/or the seasons?
por: Francic, Vito, et al.
Publicado: (2019)

Blood count in new onset atrial fibrillation after acute myocardial infarction – A hypothesis generating study
por: Distelmaier, Klaus, et al.
Publicado: (2014)

Associations of Parameters of the Tryptophan–Kynurenine Pathway with Cardiovascular Risk Factors in Hypertensive Patients
por: Theiler-Schwetz, Verena, et al.
Publicado: (2023)

Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure
por: Arfsten, Henrike, et al.
Publicado: (2019)

Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
por: Prausmüller, Suriya, et al.
Publicado: (2020)

Circulating dipeptidyl peptidase (cDPP3)—A marker for end‐stage heart failure?
por: Pavo, Noemi, et al.
Publicado: (2022)

Renin Trajectories and Outcome in Stable Heart Failure with Reduced Ejection Fraction (HFrEF) on Contemporary Therapy: A Monocentric Study from an Austrian Tertiary Hospital Outpatient Clinic
por: Han, Emilie, et al.
Publicado: (2023)

Data on gender and subgroup specific analyses of omega-3 fatty acids in the Ludwigshafen Risk and Cardiovascular Health Study
por: Kleber, Marcus E., et al.
Publicado: (2016)

Comparison of Two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations
por: Rief, Martin, et al.
Publicado: (2022)

Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer
por: Arfsten, Henrike, et al.
Publicado: (2021)

Neutrophil Activation/Maturation Markers in Chronic Heart Failure with Reduced Ejection Fraction
por: Prausmüller, Suriya, et al.
Publicado: (2022)

Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health study
por: Pusceddu, Irene, et al.
Publicado: (2019)

Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery
por: Distelmaier, Klaus, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tvis0o0khh5jloh6b1jck9su3b